» Articles » PMID: 37900424

Serum Vitamin D Level As a Risk Factor and Prognostic Marker for Acute Ischemic Stroke: A Case-Control Study at a Tertiary Care Centre in Northern India

Overview
Journal Cureus
Date 2023 Oct 30
PMID 37900424
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction Stroke is a predominant cause of death worldwide. Major risk factors for stroke in any age group are diabetes, hypertension, heart disease, smoking, and long-term alcohol abuse. It is of utmost importance to identify the risk factors for stroke to prevent recurrence. Vitamin D deficiency is identified as a risk factor for stroke. Therefore, we attempted to look for a correlation between vitamin D levels and acute ischemic stroke. Methods This observational case-control study was conducted with 150 patients (75 cases and 75 controls). On the day of admission, the National Institutes of Health Stroke Scale (NIHSS) score was calculated, and vitamin D levels were measured for each patient. The functional outcome was determined by the modified Rankin scale (mRS). Results The most common risk factors identified in this study were hypertension (61.3%), diabetes mellitus (41.3%), and smoking (37.3%). Out of 75 patients enrolled in the study, 49.4% had significant vitamin D deficiency, and 30.6% had insufficient vitamin D levels. Our study showed a significant correlation between vitamin D sufficiency in the body and the incidence of stroke (x=3.888 and p=0.048). A significant correlation (p=0.03) was found between the NIHSS score and vitamin D levels in patients with acute ischemic stroke. Conclusion In this observational case-control study, we concluded that the increasing severity of vitamin D deficiency was associated with more deaths and poor outcomes.

Citing Articles

Impact of Vitamin D Deficiency on Ischemic Stroke Severity: Insights from a Prospective Study.

Simon J, Sriharsha T, Perumal Kumaresan A, Chand U, Bose S Cureus. 2024; 16(9):e69376.

PMID: 39403669 PMC: 11472005. DOI: 10.7759/cureus.69376.

References
1.
Peters N, Herzog J, Opherk C, Dichgans M . A two-year clinical follow-up study in 80 CADASIL subjects: progression patterns and implications for clinical trials. Stroke. 2004; 35(7):1603-8. DOI: 10.1161/01.STR.0000131546.71733.f1. View

2.
Buell J, Dawson-Hughes B . Vitamin D and neurocognitive dysfunction: preventing "D"ecline?. Mol Aspects Med. 2008; 29(6):415-22. PMC: 2829975. DOI: 10.1016/j.mam.2008.05.001. View

3.
Zhang Y, Leung D, Richers B, Liu Y, Remigio L, Riches D . Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol. 2012; 188(5):2127-35. PMC: 3368346. DOI: 10.4049/jimmunol.1102412. View

4.
Guillot X, Semerano L, Saidenberg-Kermanach N, Falgarone G, Boissier M . Vitamin D and inflammation. Joint Bone Spine. 2010; 77(6):552-7. DOI: 10.1016/j.jbspin.2010.09.018. View

5.
Poungvarin N . Stroke in the developing world. Lancet. 1998; 352 Suppl 3:SIII19-22. DOI: 10.1016/s0140-6736(98)90090-3. View